The sale of Nestle’s skin health unit has attracted private equity interest with a consortium made of Cinven, Advent International and Singapore’s state fund GIC expected to bid, the Financial Times is reporting. Another group comprised of KKR, Blackstone, Sweden’s EQT and Switzerland’s Partners Group are also expected to bid, the FT said. CVC and Carlyle are also expected to submit offers, the story said. First-round bids for the unit, which makes anti-wrinkle creams and a Botox rival called Dysport, are due on Wednesday, the FT said.
Powered by WPeMatico
Comments are closed.